Sfoglia per Autore
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry
2014 P. Pedrazzoli, G. Martinelli, A.M. Gianni, G.A. Da Prada, A. Ballestrero, G. Rosti, G.L. Frassineti, M. Aieta, S. Secondino, S. Cinieri, R. Fedele, C. Bengala, M. Bregni, D. Grasso, U. De Giorgi, F. Lanza, L. Castagna, B. Bruno, M. Martino
Re-discovering NK cell allo-reactivity in the therapy of solid tumors
2016 L. Castagna, D. Mavilio
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma : a registry study by the European society for blood and marrow transplantation
2016 S. Dietrich, H. Finel, C. Martinez, J. Tischer, D. Blaise, P. Chevallier, L. Castagna, N. Milpied, A. Bacigalupo, P. Corradini, M. Mohty, M. Sanz, A. Hausmann, S. Montoto, S. Robinson, A. Boumendil, A. Sureda, P. Dreger
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
2016 S. Genadieva Stavrik, A. Boumendil, P. Dreger, K. Peggs, J. Briones, P. Corradini, A. Bacigalupo, G. Socié, F. Bonifazi, H. Finel, A. Velardi, M. Potter, B. Bruno, L. Castagna, R. Malladi, N. Russell, A. Sureda
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
2017 G. van Gorkom, M. van Gelder, D. Eikema, H. Blok, M.T. van Lint, Y. Koc, F. Ciceri, D. Beelen, P. Chevallier, D. Selleslag, D. Blaise, R. Foà, P. Corradini, L. Castagna, C. Moreno, C. Solano, L.P. Muller, J. Tischer, I. Hilgendorf, M. Hallek, J. Bittenbring, M. Theobald, J. Schetelig, N. Kroger
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
2017 F. Patriarca, L. Giaccone, F. Onida, L. Castagna, B. Sarina, V. Montefusco, A. Mussetti, N. Mordini, E. Maino, R. Greco, J. Peccatori, M. Festuccia, F. Zaja, S. Volpetti, A. Risitano, R. Bassan, P. Corradini, F. Ciceri, R. Fanin, M. Baccarani, A. Rambaldi, F. Bonifazi, B. Bruno
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis
2017 L. Castagna, A. Mussetti, R. Devillier, A. Dominietto, M. Marcatti, G. Milone, F. Maura, C. de Philippis, B. Bruno, S. Furst, D. Blaise, P. Corradini, V. Montefusco
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation : an Italian Prospective Multicenter Survey
2017 G. Corrado, B. Alice, P. Alfonso, P. Katia, A. Alessandra, B. Alessandro, C. Cattaneo, R. Anna Maria, S. Guidi, I. Anna Paola, C. Anna, I. Giuseppe, M. Giuseppe, M. Giampaolo, S. Rosanna, M. Maurizio, C. Laura, S. Simona, L. Castagna, P. Corradini, M. Francesco, P. Domenico, A. Emilio Paolo, A. Claudio, C. Fabio, S. Stella, N. Luca, F. Claudio, V. Claudio, R. Gian Maria, B. Francesca, A. Rambaldi
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party
2018 A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, K.S. Peggs, D. Blaise, B. Afanasyev, J.L. Diez-Martin, J. Sierra, A. Bloor, C. Martinez, S. Robinson, R. Malladi, J. El-Cheikh, P. Corradini, S. Montoto, P. Dreger, A. Sureda
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
2018 A. Mussetti, C. de Philippis, C. Carniti, M. Bastos-Oreiro, J. Gayoso, N. Cieri, M. Pennisi, F. Ciceri, R. Greco, J. Peccatori, F. Patriarca, J. Mariotti, L. Castagna, P. Corradini
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide
2019 J. Mariotti, D. Taurino, F. Marino, S. Bramanti, B. Sarina, L. Morabito, C. De Philippis, C. Di Vito, D. Mavilio, C. Carlo-Stella, M. Della Porta, A. Santoro, L. Castagna
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
2019 A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, D. Blaise, K.S. Peggs, B. Afanasyev, J.L. Diez-Martin, P. Corradini, D. Michonneau, S. Robinson, G. Gutiérrez García, F. Bonifazi, I. Yakoub-Agha, Z. Gülbas, A. Bloor, J. Delage, A. Esquirol, R. Malladi, C. Scheid, J. El-Cheikh, H. Ghesquières, S. Montoto, P. Dreger, A. Sureda
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC
2019 P. Dreger, A. Sureda, K.W. Ahn, M. Eapen, C. Litovich, H. Finel, A. Boumendil, A. Gopal, A.F. Herrera, C. Schmid, J.L. Diez-Martin, E. Fuchs, J. Bolaños-Meade, M. Gooptu, M.M. Al Malki, L. Castagna, S.O. Ciurea, A. Dominietto, D. Blaise, F. Ciceri, J. Tischer, P. Corradini, S. Montoto, S. Robinson, Z. Gülbas, M. Hamadani
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
2020 J. Mariotti, A.M. Raiola, A. Evangelista, A.M. Carella, M. Martino, F. Patriarca, A. Risitano, S. Bramanti, A. Busca, L. Giaccone, L. Brunello, E. Merla, L. Savino, B. Loteta, G. Console, R. Fanin, A. Sperotto, L. Marano, S. Marotta, C. Frieri, S. Sica, P. Chiusolo, S. Harbi, S. Furst, A. Santoro, A. Bacigalupo, D. Blaise, E. Angelucci, D. Mavilio, L. Castagna, B. Bruno
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma : a retrospective study of the Lymphoma Working Party—EBMT
2020 L. Bento, A. Boumendil, H. Finel, I. Khvedelidze, D. Blaise, N. Fegueux, L. Castagna, E. Forcade, P. Chevallier, N. Mordini, P. Brice, E. Deconinck, M. Gramatzki, P. Corradini, M. Hunault, M. Musso, A. Tsoulkani, D. Caballero, S. Nati, S. Montoto, A. Sureda
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
2020 L. Castagna, A. Busca, S. Bramanti, M. Raiola Anna, M. Malagola, F. Ciceri, W. Arcese, D. Vallisa, F. Patriarca, G. Specchia, R. Raimondi, R. Devillier, S. Furst, L. Giordano, B. Sarina, J. Mariotti, A. Olivieri, R. Bouabdallah, C. Carlo-Stella, A. Rambaldi, A. Santoro, P. Corradini, A. Bacigalupo, F. Bonifazi, D. Blaise
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas
2021 L. Castagna, A. Dodero, F. Patriarca, F. Onida, A. Olivieri, D. Russo, L. Giordano, I. Majolino, S. Bramanti, J. Mariotti, B. Sarina, C. De Philippis, L. Farina, C. Carlo-Stella, P. Corradini, A. Santoro
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
2021 G. Lia, C. Di Vito, S. Bruno, M. Tapparo, L. Brunello, A. Santoro, J. Mariotti, S. Bramanti, E. Zaghi, M. Calvi, L. Comba, M. Fascì, L. Giaccone, G. Camussi, E.M. Boyle, L. Castagna, A. Evangelista, D. Mavilio, B. Bruno
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 R.W. Merryman, L. Castagna, L. Giordano, V.T. Ho, P. Corradini, A. Guidetti, B. Casadei, D.A. Bond, S. Jaglowski, M.A. Spinner, S. Arai, R. Lowsky, G.L. Shah, M.-. Perales, J.M.S. De Colella, D. Blaise, A.F. Herrera, G. Shouse, C. Spilleboudt, S.M. Ansell, Y. Nieto, T. Badar, M. Hamadani, T.A. Feldman, L. Dahncke, A.K. Singh, J.P. McGuirk, T. Nishihori, J. Chavez, A.V. Serritella, J. Kline, M. Mohty, R. Dulery, A. Stamatoulas, R. Houot, G. Manson, M.-. Moles-Moreau, C. Orvain, K. Bouabdallah, D. Modi, R. Ramchandren, L. Lekakis, A. Beitinjaneh, M.J. Frigault, Y.-. Chen, R.C. Lynch, S.D. Smith, U. Rao, M. Byrne, J.T. Romancik, J.B. Cohen, S. Nathan, T. Phillips, R.M. Joyce, M. Rahimian, A. Bashey, H.J. Ballard, J. Svoboda, V. Torri, M. Sollini, C. De Philippis, M. Magagnoli, A. Santoro, P. Armand, P.L. Zinzani, C. Carlo-Stella
Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies
2021 L. Castagna, V. Valli, I. Timofeeva, R. Capizzuto, S. Bramanti, J. Mariotti, C. De Philippis, B. Sarina, D. Mannina, L. Giordano, F. De Paoli, J.J.P. van Beek, E. Zaghi, M. Calvi, C.D. Vito, D. Mavilio, R. Crocchiolo, E. Lugli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile